ACRC/Macula 2026

Join Us for the 50th Annual Atlantic Coast Retina Club (ACRC) & Macula 2026

We are pleased to announce the 50th Annual Atlantic Coast Retina Club (ACRC) and Macula 2026, taking place January 8–10, 2026, in historic Philadelphia, Pennsylvania. This milestone event will commence at Wills Eye Hospital on January 8, followed by two full days of programming at The Union League of Philadelphia on January 9–10.

The conference is expected to bring together 300–350 retina specialists. Attendees will engage with an elite faculty of renowned national and international experts who will share cutting-edge insights on the diagnosis, management, and treatment of retinal diseases.

ACRC, January 8-9, 2026, will include mystery case presentations presented by residents, fellows, and faculty in rapid succession with stimulating discussions to follow traditions established in the 1970s by giants of retina including Lawrence Yannuzzi and Jerry Shields.

Macula 2026, January 10, 2026, will feature world-renowned invited speakers who will present the latest innovations in imaging, medical retina, uveitis, tumors, retinal dystrophies, as well as pharmacologic and surgical therapies.

This landmark 50th anniversary event will provide a rich forum for education, collaboration, and innovation in the ever-evolving field of retina.

We look forward to welcoming you to Philadelphia for this exceptional academic experience!

AMA PRA Statement
Wills Eye Hospital designates this for a maximum of 17.25 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

David H Abramson, MD
MSKCC

Faculty

Thomas A. Albini, MD
BASCOM PLAMER EYE INSTITUTE

Faculty

Tomas S Aleman, MD
Scheie Eye Institute, University of Pennsylvania

Faculty

J. Fernando Arevalo, MD, PhD
Johns Hopkins' Wilmer Eye Institute

Faculty

Caroline Baumal, MD

Faculty

Audina M. Berrocal, MD
Bascom Palmer Eye Institute

Faculty

Maria Berrocal, MD

Faculty

Durga Borkar, MD

Faculty

David S Boyer, MD
Retina vitreous associates

Faculty

Consulting Fee-Acucela (Relationship has ended)|Consulting Fee-Aderum Biotechnologies, Inc.|Consulting Fee-Aerpio (Relationship has ended)|Consulting Fee-Alexion Pharmaceuticals|Consulting Fee-Allergan|Consulting Fee-Amgen|Consulting Fee-Apellis Pharmaceuticals|Consulting Fee-Astellas Pharma|Consulting Fee-Aura Biosciences|Consulting Fee-Bausch + Lomb|Consulting Fee-Bayer (Relationship has ended)|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Chengdu Kanghong Pharmaceutical|Consulting Fee-Clearside Biomedical|Consulting Fee-EyePoint Pharmaceuticals|Consulting Fee-Genentech|Consulting Fee-Glaukos Corporation|Consulting Fee-Johnson & Johnson (Relationship has ended)|Consulting Fee-Kala Pharmaceuticals|Consulting Fee-Kodiak Sciences (Relationship has ended)|Consulting Fee-Neurotech|Consulting Fee-Notal Vision (Relationship has ended)|Consulting Fee-Novartis|Consulting Fee-Ocugen|Consulting Fee-Ocular Therapeutix|Consulting Fee-Ora, Inc.|Consulting Fee-Regeneron|Consulting Fee-REGENXBIO, Inc.|Consulting Fee-Sanofi|Consulting Fee-Santen Pharmaceuticals|Consulting Fee-Roche|Consulting Fee-Sun Pharmaceutical Industries|Consulting Fee-Unity Biotechnology|Consulting Fee-LumiThera

Neil M. M. Bressler, MD
Johns Hopkins University School of Medicine

Faculty

Susan B. Bressler, MD
Johns Hopkins University School of Medicine

Faculty

Peter Campochiaro, MD

Faculty

Advisor-Boehringer Ingelheim (Relationship has ended)|Consulting Fee-Bausch + Lomb (Relationship has ended)|Grant or research support-Celanese (Relationship has ended)|Consulting Fee-Clearside Biomedical (Relationship has ended)|Consulting Fee-Cove|Grant or research support-Cove|Stocks or stock options, excluding diversified mutual funds-Cove|Advisor-ExgenesisBio (Relationship has ended)|Consulting Fee-Exonate|Advisor-Genentech|Grant or research support-Genentech|Grant or research support-Ocular Therapeutix (Relationship has ended)|Advisor-Merck|Advisor-Perfuse|Grant or research support-REGENXBIO, Inc.

R.V. Paul Chan, MD, MSc, MBA
Illinois Eye and Ear Infirmary, University of Illinois at Chicago

Faculty

Jay Chhablani, MD
University of Pittsburgh Medical Center

Faculty

Allen Chiang, MD
Wills Eye Hospital

Faculty

Grant or research support-Genentech|Grant or research support-Apellis Pharmaceuticals

Donald J. D'Amico, MD
Weill Cornell Medical College/New York-Presbyterian Hospital

Faculty

Jordan Deaner, MD
Mid Atlantic Retina, Wills Eye Hospital

Faculty

Jay Duker, MD

Faculty

James P. Dunn, MD
Retina Division/Wills Eye Hospital

Faculty

Justis P Ehlers, MD
Cleveland Clinic

Faculty

Dean Eliott, MD
Massachusetts Eye & Ear

Faculty

Philip J. Ferrone, MD
VRCNY

Faculty

Jasmine H. Francis, MD
MSK

Faculty

Jasmine Francis, MD, FACS

Faculty

K. Bailey Freund, MD
Vitreous Retina Macula Consultants of New York

Faculty

Sunir J. Garg, MD
MidAtlantic Retina, The Retina Service of Wills Eye Hospital

Faculty

Consulting Fee-Bausch + Lomb|Consulting Fee-Johnson & Johnson (Relationship has ended)|Consulting Fee-Allergan (Relationship has ended)|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Apellis Pharmaceuticals|Consulting Fee-Merck|Consulting Fee-Regeneron|Consulting Fee-Coherus Biosciences (Relationship has ended)|Grant or research support-Allergan (Relationship has ended)|Grant or research support-Boehringer Ingelheim|Grant or research support-Genentech|Grant or research support-Regeneron|Grant or research support-Apellis Pharmaceuticals|Grant or research support-NGM Bio (Relationship has ended)|Grant or research support-Kodiak Sciences (Relationship has ended)|Grant or research support-Alcon|Consulting Fee-Zeiss|Consulting Fee-Merck

James Handa, MD
Wilmer Eye Institute, Johns Hopkins University

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Character Biosciences|Paid consultant-FerRx|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Cirrus Therapeutics

Jason Hsu, MD
Wills Eye Physicians-Mid Atlantic Retina

Faculty

Douglas Jabs, MD, MBA

Faculty

Nothing to disclose

Glenn Jaffe, MD

Faculty

Talia Kaden, MD

Faculty

Richard S. Kaiser, MD
Mid Atlantic Retina

Faculty

Nothing to disclose

Benjamin J. Kim, MD
Scheie Eye Institute of UPenn

Faculty

Ivana K. Kim, MD
Massachusetts Eye and Ear

Faculty

Consulting Fee-Kodiak Sciences

Michael Klufas, MD
Mid Atlantic Retina/Wills Eye

Faculty

Ajay E. Kuriyan, MD
Mid Atlantic Retina/Wills Eye Hospital

Faculty

Stocks or stock options, excluding diversified mutual funds-Recens medical|Grant or research support-4DMT|Speakers Bureau-Genentech|Speakers Bureau-Astellas Pharma|Consulting Fee-Alimera Sciences|Grant or research support-Alcon|Grant or research support-Aderum Biotechnologies, Inc.|Consulting Fee-Allergan|Consulting Fee-Bausch + Lomb|Consulting Fee-Spark Therapeutics|Consulting Fee-EyePoint Pharmaceuticals|Grant or research support-EyePoint Pharmaceuticals|Consulting Fee-Genentech|Grant or research support-Genentech|Consulting Fee-LifeNet Health|Consulting Fee-Novartis|Consulting Fee-Optos, Inc.|Grant or research support-Annexon

Sara E. Lally, MD
Shields and Shields

Faculty

Nothing to disclose

Sara Lally, MD
Wills Eye Hospital

Faculty

Ferhina Li, MD, MPH

Faculty

Sonia Mehta, MD
Wills Eye Hospital

Faculty

Phoebe Mellen, MD
Tufts Medical Center

Faculty

John Miller, MD

Faculty

Yasha S. Modi, MD
New York University

Faculty

Jose Pulido, MD, MS, MPH, MBA
Wills Eye

Faculty

Nothing to disclose

Ehsan Rahimy, MD
Palo Alto Medical Foundation

Faculty

Richard B. Rosen, MD, ScD(hon),FACS, FASRS, FARVO
New York Eye and Ear Infirmary of Mount Sinai

Faculty

Drew Scoles, MD, PhD
CHOP

Faculty

Consulting Fee-Neolight (Relationship has ended)

Adrienne W. Scott, MD
Johns Hopkins

Faculty

Rishi Singh, MD

Faculty

Meera Sivalingam, MD
Wills Eye Hospital

Faculty

Sunil Srivastava, MD

Faculty

Matt Starr, MD
Mayo Clinic

Faculty

Advisor-Allergan (Relationship has ended)|Advisor-REGENXBIO, Inc.|Advisor-Alimera Sciences|Advisor-Genentech|Consulting Fee-Gyroscope Therapeutics|Advisor-EyePoint Pharmaceuticals|Advisor-Longbridge Medical|Advisor-Evolve Medical

Katherine Talcott, MD
Cole Eye Institute

Faculty

John T. Thompson, MD
Retina Specialists

Faculty

Stephen H. Tsang, MD
Columbia University

Faculty

James F. Vander, MD
MidAtlantic Retina, The Retina Service of Wills Eye Hospital

Faculty

Nothing to disclose

James Vander, MD

Faculty

Demetrios Vavvas, MD
Mass Eye and Ear Harvard Medical School

Faculty

Demetrios Vavvas, MD, PhD

Faculty

Andre J. Witkin, MD
Tufts Medical Center

Faculty

Lawrence A. Yannuzzi, MD
The Macula Foundation, Inc.

Faculty

Nicholas Yannuzzi, MD
Bascom Palmer Eye Institute

Faculty

Yi Zhang, MD, PhD

Faculty

Alexander J. Brucker, MD
Scheie Eye Institute, University of Pennsylvania

Faculty, Planner

Grant or research support-Novo Nordisk Pharmaceuticals, Inc.|Grant or research support-4D Molecular Therapeutics|Grant or research support-Genentech

Julia A. Haller, MD
Wills Eye

Faculty, Planner

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol Myers Squibb|Stocks or stock options, excluding diversified mutual funds-Bristol Myers Squibb|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Opthea|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Outlook Therapeutics|Stocks or stock options, excluding diversified mutual funds-Outlook Therapeutics|Stocks or stock options, excluding diversified mutual funds-Opthea|Consulting Fee-Regeneron|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Aura Biosciences (Relationship has ended)|Consulting Fee-Aura Biosciences (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bionic Sight LLC|Consulting Fee-Bionic Sight LLC|Consulting Fee-Seeing Medicine (Relationship has ended)

Allen Ho, MD
Mid Atlantic Retina

Faculty, Planner

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Alcon|Consulting Fee-Aerie Pharmaceuticals|Grant or research support-Aerie Pharmaceuticals|Consulting Fee-Aldeyra|Grant or research support-Aldeyra|Consulting Fee-Astellas Pharma|Consulting Fee-Atsena|Grant or research support-Atsena|Consulting Fee-Chengdu Kanghong Pharmaceutical|Grant or research support-Chengdu Kanghong Pharmaceutical|Consulting Fee-Clearside Biomedical|Consulting Fee-Annexon|Grant or research support-Annexon|Grant or research support-Astellas Pharma|Other: Equity-Covalent Medical, LLC|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Allergan|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Apellis Pharmaceuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech|Independent Contractor (included contracted research)-Kodiak Sciences (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Notal Vision|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Regeneron|Membership on Advisory Committees or Review Panels, Board Membership, etc.-REGENXBIO, Inc.|Grant or research support-4DMT|Consulting Fee-Aavantgarde Bio|Consulting Fee-AcuSurgical|Consulting Fee-Adverum|Grant or research support-Adverum|Consulting Fee-Dompé |Consulting Fee-Emmecell|Consulting Fee-EyePoint Pharmaceuticals|Grant or research support-EyePoint Pharmaceuticals|Consulting Fee-Eyevensys|Consulting Fee-Janssen|Grant or research support-Janssen|Consulting Fee-Kiora|Grant or research support-Kiora|Consulting Fee-Lineage|Grant or research support-Lineage|Consulting Fee-Lumithera|Grant or research support-Lumithera|Consulting Fee-Nanoscope|Grant or research support-Nanoscope|Grant or research support-National Eye Institute|Consulting Fee-Notal Vision|Grant or research support-Notal Vision|Consulting Fee-Ocular Therapeutix|Consulting Fee-ONL|Other: Equity-ONL|Consulting Fee-Oxular|Grant or research support-ProQR|Consulting Fee-Stealth|Consulting Fee-Vanotech

Carol L. Shields, MD
Shields and Shields MD PC

Faculty, Planner

Advisor-Aura Biosciences|Advisor-Ideaya Biosciences|Advisor-Immunocore|Advisor-iOnctura

Arunan Sivalingam, MD
Retina Service, Wills Eye

Faculty, Planner

Nothing to disclose

Carl D. Regillo, MD
Wills Eye-MAR

Faculty, XX - Co-Director

Consulting Fee-Allergan|Consulting Fee-Apellis Pharmaceuticals|Consulting Fee-EyePoint Pharmaceuticals|Consulting Fee-Genentech|Consulting Fee-Novartis|Consulting Fee-Ocugen|Consulting Fee-REGENXBIO, Inc.|Consulting Fee-Regeneron|Consulting Fee-Astellas Pharma|Consulting Fee-Ocular Therapeutix|Consulting Fee-Zeiss (Relationship has ended)|Consulting Fee-Aderum Biotechnologies, Inc.|Consulting Fee-Alcon|Consulting Fee-Bausch + Lomb|Consulting Fee-Boehringer Ingelheim

Yoshihiro Yonekawa, MD
Wills Eye Hospital / Mid Atlantic Retina

Faculty, XX - Course Director

Consulting Fee-Alcon (Relationship has ended)|Consulting Fee-Bausch + Lomb (Relationship has ended)|Consulting Fee-Apellis Pharmaceuticals (Relationship has ended)|Consulting Fee-Genentech|Grant or research support-Genentech|Grant or research support-Regeneron|Grant or research support-Ocugen|Grant or research support-Kyowa Kirin|Grant or research support-Eyebiotech